ClinicalTrials.gov
public full text
Public Domain
Clinical Trial of Green Tea Catechins in Men on Active Surveillance
This randomized double-blinded Phase II clinical trial will evaluate the bioavailability, safety, effectiveness and validate the mechanism by which a standardized formulation of whole Green Tea Catechin, (Sunphenon® 90D) containing 405 mgs vs. Placebo, administered for 24 months in a cohort of men with low to intermediate grade prostate managed on active surveillance
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The BIOPRES Trial: Transrectal BIOpsies of the PRostate: End Versus Side-firing#869229
- Measurements of Sexual Steroids' Concentrations in Prostatic Tissue#1074181
- Prostate Cancer Active Surveillance Trigger Trial (PCASTT-UK): Comparing Current Practice for Men With Prostate Cancer on Active Surveillance (AS) to an AS Protocol With Standardised Triggers for Transitioning to Curative Treatment#1162466
- Effects of a Genistein Concentrated Polysaccharide (GCP) for Prostate Cancer on Active Surveillance.#1125617
- Safety of Prasaprohyai 95%Ethanolic Extract Capsules in Healthy Volunteer#904460
Record · ID 858526
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive